Grant RadarWorldwide funding

Browse grants Log in Get started

Health Open for ApplicationsPAR-25-095

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-25-095

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthPAR-25-095Grants.gov

Related Grants

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Amount not stated

07 Jan 2027(62d)

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET

Amount not stated

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)

Amount not stated

06 Oct 2028(700d)

Health and Extreme Weather Solutions-Focused Research Hubs (U54 - Clinical Trial Optional)

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

6 November 2026

Closes today!

Opens: 18 Nov 2024

Programme Details

Programme Code

PAR-25-095